CRM vs IBM
CRM and IBM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRMSalesforce, Inc. | IBMINTERNATIONAL BUSINESS MACHINES CORP |
|---|---|---|
| Market cap | $211.42B | $218.17B |
| P/E (TTM) | 23.5 | 20.5 |
| P/B | 5.51 | 6.33 |
| P/S | 5.1x | 3.2x |
| Dividend yield | 0.75% | 2.87% |
| Revenue | $43.94B(TTM) | $69.09B(TTM) |
| Revenue growth (YoY) | 9.6% | 7.6% |
| Net income | $9.66B(TTM) | $10.72B(TTM) |
| Earnings growth (YoY) | 20.3% | 75.9% |
| EPS, diluted | $10.92(TTM) | $11.29(TTM) |
| EBIT margin | 20.1% | 18.2% |
| ROE | 19.4% | 30.7% |
| ROIC | 9.4% | 13.1% |
| Piotroski F | 6/9 | 7/9 |
| 1y total return | +0.9% | -2.4% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRM frente a IBM
| Métrica | CRM | IBM |
|---|---|---|
| Valor final | $33.8K | $24.6K |
| Retorno total | +238.3% | +146.3% |
| CAGR | +12.5% | +9.1% |
| Volatilidad | 36.1% | 28.0% |
| Sharpe | 0.40 | 0.31 |
| Sortino | 0.58 | 0.43 |
| Caída máxima | -58.7% | -40.6% |
Basado en 2600 días de negociación comunes, 2016-05-02 → 2026-09-02 · tasa libre de riesgo 3.92% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)